We thank Drs. McCann and Ricaurte (2000) for their comments because they give us the opportunity to ad-dress some misconceptions about the relevance of inter-species scaling to 3,4-methylenedioxymethamphet-amine (MDMA) neurotoxicity and also to make it clear that we have not taken our responsibilities lightly in the design of a clinical study with MDMA.
